top of page
Search
  • Ann Tucker
    • Jan 27
    • 1 min read

Deaths Involving Buprenorphine Did Not Increase With COVID-19 Prescriber Flexibility

NIDA (1/20) –– The proportion of opioid overdose deaths involving buprenorphine did not increase in the months after prescribing flexibilities were put in place during the COVID-19 pandemic. [...] These data are consistent with a recent study reporting that COVID-era expansion of methadone access for the treatment of opioid use disorder was not associated with an increase in methadone-involved overdose deaths. Read more




0 views0 comments

Recent Posts

See All

U.S. House | This week, the House Oversight and Accountability Committee held a hearing on “Oversight and Reauthorization of the Office of National Drug Control Policy." Dr. Rahul Gupta, ONDCP Directo

DEA [3/22] | In a public safety alert, the DEA said it observed a sharp increase in the trafficking of fentanyl mixed with xylazine, a sedative also known as “Tranq” that has been approved by the Food

bottom of page